| Noel Gutierrez, MD | |
|
789 W 27th St Ste 1, Yuma, AZ 85364-7207 | |
| (928) 344-8400 | |
| (928) 344-8412 |
| Full Name | Noel Gutierrez |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 27 Years |
| Location | 789 W 27th St Ste 1, Yuma, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366475394 | NPI | - | NPPES |
| 240178 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 4301073797 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Yuma Regional Medical Center | Yuma, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southwest Heart And Vascular Care, Ltd | 1052478930 | 2 |
News Archive
Researchers of the Fraunhofer Institute for Molecular Biology and Applied Ecology IME have developed software for Germany that calculates the concentration of pesticides/plant protection products in surface waters like ditches or streams. The new process can be employed as a component of pesticide authorization procedures.
A new study in rats could begin to explain why allergies during pregnancy are linked to higher risks for attention-deficit hyperactivity disorder and autism in children.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced positive results from their second placebo-controlled Phase 1 study with RXI‑109, an sd-rxRNA compound that targets Connective Tissue Growth Factor, and is being developed for the treatment of abnormal dermal scars such as hypertrophic scars and keloids in conjunction with scar revision surgery.
The wide range of manifestations of COVID-19 has continued to baffle investigators. Now, a new study published on the preprint server medRxiv in June 2020 shows that blood proteins in COVID-19 patients change over time, and these can possibly predict or reflect the severity of disease. More, they may present targets for treatment.
› Verified 8 days ago
| Entity Name | Southwest Heart And Vascular Care, Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902071590 PECOS PAC ID: 1052478930 Enrollment ID: O20090319000583 |
News Archive
Researchers of the Fraunhofer Institute for Molecular Biology and Applied Ecology IME have developed software for Germany that calculates the concentration of pesticides/plant protection products in surface waters like ditches or streams. The new process can be employed as a component of pesticide authorization procedures.
A new study in rats could begin to explain why allergies during pregnancy are linked to higher risks for attention-deficit hyperactivity disorder and autism in children.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced positive results from their second placebo-controlled Phase 1 study with RXI‑109, an sd-rxRNA compound that targets Connective Tissue Growth Factor, and is being developed for the treatment of abnormal dermal scars such as hypertrophic scars and keloids in conjunction with scar revision surgery.
The wide range of manifestations of COVID-19 has continued to baffle investigators. Now, a new study published on the preprint server medRxiv in June 2020 shows that blood proteins in COVID-19 patients change over time, and these can possibly predict or reflect the severity of disease. More, they may present targets for treatment.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Noel Gutierrez, MD 789 W 27th St Ste 1, Yuma, AZ 85364-7207 Ph: (928) 344-8400 | Noel Gutierrez, MD 789 W 27th St Ste 1, Yuma, AZ 85364-7207 Ph: (928) 344-8400 |
News Archive
Researchers of the Fraunhofer Institute for Molecular Biology and Applied Ecology IME have developed software for Germany that calculates the concentration of pesticides/plant protection products in surface waters like ditches or streams. The new process can be employed as a component of pesticide authorization procedures.
A new study in rats could begin to explain why allergies during pregnancy are linked to higher risks for attention-deficit hyperactivity disorder and autism in children.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced positive results from their second placebo-controlled Phase 1 study with RXI‑109, an sd-rxRNA compound that targets Connective Tissue Growth Factor, and is being developed for the treatment of abnormal dermal scars such as hypertrophic scars and keloids in conjunction with scar revision surgery.
The wide range of manifestations of COVID-19 has continued to baffle investigators. Now, a new study published on the preprint server medRxiv in June 2020 shows that blood proteins in COVID-19 patients change over time, and these can possibly predict or reflect the severity of disease. More, they may present targets for treatment.
› Verified 8 days ago
Dr. Augustine W Lau, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 2375 S. Ridgeview Drive, Yuma, AZ 85364 Phone: 928-317-2518 Fax: 928-317-1811 | |
Ashvin K Shah, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2110 W 24th St, Yuma, AZ 85364 Phone: 928-344-1891 Fax: 928-726-6306 | |
Aleix M. Bazzi, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2095 W. 24th Street, Suite C, Yuma, AZ 85364 Phone: 928-314-1200 Fax: 928-314-1201 | |
Dr. Vernon Barros Chavez, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1210 W 24th St, Suite 2, Yuma, AZ 85364 Phone: 928-726-2500 Fax: 928-726-7853 | |
Dr. Julian J. Nicholas, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2400 S Avenue A, Yuma, AZ 85364 Phone: 928-344-2000 | |
Dr. Jeanne Notto Elnadry, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 2244 S Avenue A, Suite A, Yuma, AZ 85364 Phone: 928-276-4477 Fax: 928-276-4481 | |
Shahid Mansoor, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 11518 N Frontage Rd Ste A, Yuma, AZ 85367 Phone: 928-342-6500 Fax: 928-342-6863 |